ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. Join us Jan. 14 for a virtual discussion about our Rx ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Fodor's Travel has released its 2026 "No List" to highlight destinations struggling with overtourism. The list encourages travelers to reconsider visiting these places to give them a break from ...
They’ve got nos in different area codes. Fodor’s has released its 2026 “No List,” highlighting destinations where tourism is “placing unsustainable pressures on the land and local communities.” The ...
Indio is one of six destinations on Fodor’s Travel 2026 list of the top places to visit in the United States, the city announced on Friday. Fodor’s Travel is known for providing information on tourism ...
ORLANDO, Fla., Nov. 13, 2025 /PRNewswire/ -- Ingenus Pharmaceuticals today announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of Conjugated Estrogens Tablets, USP, ...
The generic product is now available nationwide in strengths of 0.3mg, 0.45mg, 0.625mg, 0.9mg, and 1.25mg. The Food and Drug Administration (FDA) has approved the first generic version of Premarin ® ...
A new analysis has raised concerns about the Cigna Group’s drug pricing strategy, finding that one of its subsidiaries, Quallent Pharmaceuticals, often charges more for generic medications than ...
While an argument to re-integrate JavaFX floats in an OpenJDK discussion list, Oracle ponders providing better access to JavaFX from the JDK. Just as a proposal to return JavaFX to the Java ...
Jamie Dimon is right to be alarmed about our national-security vulnerabilities, especially an overreliance on China and India for generic prescription drugs (“Investments for National Security,” op-ed ...
President Trump has delayed imposing tariffs on pharmaceuticals to allow for more negotiations with drug companies. (Francis Chung/Bloomberg News) The Trump administration says it doesn't plan to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results